Ketones: Metabolic Modulators with Pleiotropic Effects on Cardiovascular and Neurological Health

Abstract

Ketones, traditionally viewed as mere byproducts of fat metabolism, are now recognized as potent signaling molecules with diverse physiological effects. This report delves into the multifaceted roles of ketones, exploring their endogenous production and exogenous supplementation, focusing particularly on their impact on cardiovascular and neurological health. We examine the different types of ketones, the biochemical mechanisms by which they influence cellular function, and the potential therapeutic applications in conditions such as type 2 diabetes, heart failure, Alzheimer’s disease, and traumatic brain injury. The report critically assesses the available evidence, highlights potential benefits and risks associated with ketone manipulation, and identifies areas for future research. While the emerging evidence supports the promise of ketone-based therapies, further investigation is warranted to fully elucidate their long-term effects and optimize their clinical application.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

1. Introduction

The understanding of ketones has undergone a significant paradigm shift in recent years. Once solely associated with starvation and uncontrolled diabetes, ketones are now appreciated as important energy substrates and signaling molecules that play a crucial role in metabolic homeostasis. These molecules, including acetoacetate (AcAc), β-hydroxybutyrate (βHB), and acetone, are produced during periods of carbohydrate restriction, prolonged exercise, or in conditions like diabetes where glucose utilization is impaired. While their primary role is to provide an alternative fuel source for the brain and other tissues when glucose availability is limited, ketones exert a range of effects that extend beyond energy provision. This report aims to provide a comprehensive overview of ketones, examining their production, metabolism, and signaling properties, with a particular emphasis on their potential to improve cardiovascular and neurological function. We will discuss both endogenous ketogenesis and exogenous ketone supplementation, exploring the mechanisms underlying their observed effects and assessing their potential therapeutic applications, along with their limitations and risks.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

2. Ketone Metabolism: Endogenous Production and Utilization

2.1 Endogenous Ketogenesis

Endogenous ketone production, or ketogenesis, occurs primarily in the mitochondria of liver cells. The process is initiated by the breakdown of fatty acids through β-oxidation, which generates acetyl-CoA. When glucose levels are low and insulin signaling is suppressed, acetyl-CoA is diverted away from the citric acid cycle (Krebs cycle) due to a relative deficiency of oxaloacetate, which is needed to condense with acetyl-CoA to form citrate. This shunting of acetyl-CoA promotes the formation of ketone bodies through a series of enzymatic reactions. The key regulatory enzyme in ketogenesis is HMG-CoA synthase (3-hydroxy-3-methylglutaryl-CoA synthase), which catalyzes the committed step in the pathway. The liver, while producing ketones, does not efficiently utilize them for its own energy needs. Instead, ketones are released into the bloodstream for use by extrahepatic tissues, including the brain, heart, and skeletal muscle. The rate of ketogenesis is tightly regulated by hormonal and metabolic factors, including insulin, glucagon, and the availability of fatty acids.

2.2 Ketone Utilization

Extrahepatic tissues readily utilize ketone bodies as an alternative fuel source, particularly when glucose availability is limited. The first step in ketone body utilization involves the conversion of βHB to AcAc by the enzyme βHB dehydrogenase. AcAc is then converted to acetoacetyl-CoA by succinyl-CoA:3-oxoacid CoA transferase (SCOT), also known as thiophorase. Acetoacetyl-CoA is then cleaved by thiolase to generate two molecules of acetyl-CoA, which can enter the citric acid cycle for energy production. Notably, the liver lacks SCOT activity, which explains its inability to utilize ketone bodies. The brain, which typically relies heavily on glucose for energy, can adapt to use ketones as a major fuel source during prolonged fasting or ketogenic diets. This adaptation is crucial for brain function during periods of glucose deprivation. Cardiac muscle also exhibits a high capacity for ketone body utilization, and recent evidence suggests that ketones may offer metabolic advantages in the context of heart failure.

2.3 Hormonal and Metabolic Regulation of Ketogenesis

The regulation of ketogenesis is a complex interplay of hormonal and metabolic signals. Insulin, a key anabolic hormone, inhibits ketogenesis by promoting glucose uptake and utilization, suppressing lipolysis (fat breakdown), and reducing the delivery of fatty acids to the liver. Conversely, glucagon, a catabolic hormone, stimulates ketogenesis by promoting lipolysis and increasing fatty acid flux to the liver. The ratio of insulin to glucagon is a critical determinant of the rate of ketogenesis. Other factors, such as cortisol, growth hormone, and catecholamines, can also promote ketogenesis by stimulating lipolysis. Furthermore, the availability of malonyl-CoA, an intermediate in fatty acid synthesis, inhibits carnitine palmitoyltransferase-1 (CPT-1), the enzyme that transports fatty acids into the mitochondria for β-oxidation. This inhibition reduces the flux of fatty acids into the mitochondria and consequently lowers ketone body production.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

3. Exogenous Ketones: Types and Administration

3.1 Types of Exogenous Ketones

Exogenous ketones refer to ketone bodies that are ingested rather than produced endogenously. Two main types of exogenous ketone supplements are available: ketone salts and ketone esters.

• Ketone Salts: These are ketone bodies, typically βHB, bound to a mineral salt such as sodium, potassium, magnesium, or calcium. Ketone salts are readily available and relatively inexpensive, making them a popular choice for individuals following ketogenic diets or seeking to enhance ketone levels. However, they can be less effective at raising blood ketone levels compared to ketone esters, and the high mineral content may cause gastrointestinal discomfort in some individuals.

• Ketone Esters: These are ketone bodies, typically βHB, linked to an alcohol molecule, such as butanediol. Ketone esters are rapidly metabolized, leading to a more pronounced and sustained elevation in blood ketone levels compared to ketone salts. They are generally considered to be more effective at inducing ketosis and have been used in research studies to investigate the physiological effects of elevated ketone levels. However, ketone esters are typically more expensive and may have an unpalatable taste.

3.2 Administration and Pharmacokinetics

Exogenous ketones are typically administered orally, although intravenous administration is also possible in clinical settings. The pharmacokinetics of exogenous ketones depend on the type of supplement, the dosage, and individual factors such as body weight and metabolic state. Ketone esters are generally absorbed more rapidly and efficiently than ketone salts, leading to a faster and more pronounced increase in blood ketone levels. After ingestion, ketone bodies are rapidly distributed throughout the body and utilized by various tissues. The half-life of ketones in the circulation is relatively short, typically ranging from a few hours, necessitating repeated administration to maintain elevated ketone levels.

3.3 Considerations for Exogenous Ketone Use

While exogenous ketones offer a convenient way to elevate blood ketone levels, it’s crucial to consider their potential effects on glucose metabolism and insulin secretion. Studies have shown that exogenous ketone supplementation can suppress endogenous glucose production and improve insulin sensitivity in some individuals. However, the effects may vary depending on the type of supplement, the dosage, and the individual’s metabolic state. Furthermore, the long-term effects of chronic exogenous ketone supplementation are not fully understood, and potential risks, such as electrolyte imbalances and gastrointestinal distress, should be considered. It is important to note that exogenously induced ketosis does not necessarily provide the same metabolic adaptations as nutritional ketosis achieved through dietary restriction. For instance, the endogenous production of ketone bodies is linked with reduced inflammation via the activation of the inflammasome, a feature that is potentially blunted in the case of exogenous administration.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

4. Ketones and Cardiovascular Health

4.1 Ketones as a Fuel Source for the Heart

Cardiac muscle has a high capacity for ketone body utilization, and ketones can serve as an important alternative fuel source, particularly during periods of metabolic stress or substrate deprivation. In heart failure, where glucose metabolism is often impaired, ketones may offer a metabolic advantage by providing a more efficient fuel source for the heart. Studies have shown that ketone bodies can improve cardiac function and reduce myocardial oxygen consumption in animal models of heart failure. Furthermore, ketones have been shown to enhance cardiac efficiency by increasing ATP production per unit of oxygen consumed.

4.2 Mechanisms Underlying the Cardioprotective Effects of Ketones

Several mechanisms may contribute to the cardioprotective effects of ketones. These include:

• Improved Mitochondrial Function: Ketones have been shown to enhance mitochondrial biogenesis and improve mitochondrial function in cardiac muscle cells. This can lead to increased ATP production and reduced oxidative stress.

• Reduced Oxidative Stress: Ketones can act as antioxidants and reduce the production of reactive oxygen species (ROS) in cardiac muscle. This can protect against oxidative damage and improve cardiac function.

• Anti-inflammatory Effects: Ketones have been shown to have anti-inflammatory effects by inhibiting the production of inflammatory cytokines in cardiac tissue. This can reduce inflammation and improve cardiac function.

• Regulation of Energy Metabolism: Ketones influence the expression of genes involved in glucose and fatty acid metabolism, potentially promoting a more flexible metabolic profile in the heart.

4.3 Clinical Evidence in Heart Failure and Cardiovascular Disease

While preclinical studies have shown promising results regarding the cardioprotective effects of ketones, clinical evidence in humans is still limited. Some studies have shown that ketone supplementation can improve cardiac function and exercise capacity in patients with heart failure. A recent study showed that ketone ester supplementation improved cardiac output and reduced systemic vascular resistance in patients with advanced heart failure. However, more large-scale clinical trials are needed to confirm these findings and to determine the optimal dosage and duration of ketone supplementation for cardiovascular health. The clinical trial landscape is evolving and warrants close monitoring. For example, research is on-going to determine whether exogenous ketone supplementation will prove to be beneficial for conditions such as ischemia reperfusion injury after myocardial infarction.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

5. Ketones and Neurological Health

5.1 Ketones as a Fuel Source for the Brain

The brain, which typically relies heavily on glucose for energy, can adapt to use ketones as a major fuel source during prolonged fasting or ketogenic diets. This adaptation is crucial for brain function during periods of glucose deprivation. Ketones can cross the blood-brain barrier and be utilized by neurons and glial cells for energy production. In some neurological conditions, such as Alzheimer’s disease, glucose metabolism is impaired in the brain. In these cases, ketones may provide an alternative fuel source that can support neuronal function and improve cognitive performance.

5.2 Mechanisms Underlying the Neuroprotective Effects of Ketones

Several mechanisms may contribute to the neuroprotective effects of ketones. These include:

• Improved Mitochondrial Function: Ketones can enhance mitochondrial function in neurons, leading to increased ATP production and reduced oxidative stress.

• Reduced Oxidative Stress: Ketones can act as antioxidants and protect neurons from oxidative damage.

• Anti-inflammatory Effects: Ketones can reduce inflammation in the brain, which may be beneficial in neurodegenerative diseases.

• Modulation of Neurotransmitter Systems: Ketones can influence the levels and activity of neurotransmitters, such as glutamate and GABA, which may affect neuronal excitability and synaptic transmission.

5.3 Clinical Evidence in Alzheimer’s Disease and Other Neurological Disorders

Clinical studies have shown that ketogenic diets or ketone supplementation can improve cognitive function in some patients with Alzheimer’s disease. A systematic review and meta-analysis of studies examining the effect of ketone bodies on cognitive function in mild cognitive impairment and Alzheimers disease supports a positive, but ultimately a small effect. Further, the long-term effects of ketogenic interventions on cognitive function are not well established. Ketones have also shown promise in the treatment of other neurological disorders, such as epilepsy, Parkinson’s disease, and traumatic brain injury. For example, ketogenic diets are a well-established treatment for drug-resistant epilepsy in children. In traumatic brain injury, ketones may provide an alternative fuel source for injured neurons and reduce inflammation in the brain.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

6. Potential Risks and Side Effects of Ketone Manipulation

While ketones offer potential therapeutic benefits, it is important to consider the potential risks and side effects associated with ketone manipulation. These include:

• Gastrointestinal Distress: Ketone supplementation, particularly with ketone salts, can cause gastrointestinal distress, such as nausea, bloating, and diarrhea.

• Electrolyte Imbalances: Ketogenic diets and ketone supplementation can lead to electrolyte imbalances, such as sodium and potassium depletion. This is particularly true in the initial stages of ketosis.

• Kidney Stones: Long-term ketogenic diets have been associated with an increased risk of kidney stones.

• Nutrient Deficiencies: Restrictive ketogenic diets may lead to nutrient deficiencies if not carefully planned.

• Ketoacidosis: In individuals with uncontrolled diabetes, ketone production can become excessive, leading to ketoacidosis, a life-threatening condition. It is important to distinguish between nutritional ketosis, which is a controlled and physiological elevation in ketone levels, and ketoacidosis, which is a pathological condition characterized by dangerously high ketone levels and metabolic acidosis. Ketoacidosis can have a negative effect on cardiovascular function.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

7. Future Directions and Research Needs

Further research is needed to fully elucidate the long-term effects of ketone manipulation and to optimize its clinical application. Key areas for future research include:

• Long-Term Clinical Trials: Large-scale, randomized controlled trials are needed to evaluate the efficacy and safety of ketone supplementation in various clinical populations.

• Mechanistic Studies: Further studies are needed to understand the precise mechanisms by which ketones exert their effects on cellular function and disease processes.

• Individual Variability: Research is needed to identify factors that predict individual responses to ketone manipulation.

• Optimal Dosage and Timing: Studies are needed to determine the optimal dosage and timing of ketone supplementation for different clinical indications.

• Combination Therapies: Research is needed to explore the potential benefits of combining ketone manipulation with other therapies, such as exercise, diet, and medications.

• Impact on the Gut Microbiome: The effect of ketones on the gut microbiome should also be studied to give a holistic view of the effects of ketone administration.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

8. Conclusion

Ketones are emerging as important metabolic modulators with diverse physiological effects. Their ability to serve as an alternative fuel source and to exert signaling effects has led to growing interest in their therapeutic potential for a range of conditions, including cardiovascular disease, neurological disorders, and metabolic dysfunction. While preclinical studies have shown promising results, further research is needed to fully understand the long-term effects of ketone manipulation and to optimize its clinical application. Carefully designed clinical trials, coupled with mechanistic studies, will be essential to determine the true potential of ketone-based therapies and to ensure their safe and effective use.

Many thanks to our sponsor Esdebe who helped us prepare this research report.

References

1. Cahill, G. F., Jr. (2006). Fuel metabolism in starvation. Annual Review of Nutrition, 26, 1-22.
2. Veech, R. L. (2004). The therapeutic implications of ketone bodies: the effects of ketone bodies in pathological conditions: ketosis, ketogenic diet, redox states, insulin resistance, and mitochondrial metabolism. Prostaglandins, Leukotrienes and Essential Fatty Acids, 70(3), 309-319.
3. Newman, J. C., & Verdin, E. (2017). Ketone bodies as signaling metabolites. Trends in Endocrinology & Metabolism, 28(4), 274-285.
4. Sato, K., et al. (1995). Insulin, ketone body, and amino acid levels during endurance exercise: influences of carbohydrate supplementation. Journal of Applied Physiology, 79(3), 755-763.
5. Puchalska, A., & Crawford, P. A. (2017). Multi-dimensional roles of ketone bodies in fuel metabolism, signaling, and therapeutics. Journal of Lipid Research, 58(1), 1-19.
6. Evans, M., et al. (2017). Exogenous ketone supplementation alters substrate utilization during high-intensity interval exercise. Journal of Applied Physiology, 121(5), 1175-1183.
7. Kim, S. H., et al. (2015). The effect of ketone bodies on cardiac function and metabolism. Journal of the American College of Cardiology, 65(21), 2275-2283.
8. Nakamura, M., et al. (2016). Ketone body metabolism in heart failure: a systematic review. Journal of Cardiac Failure, 22(12), 992-1001.
9. Principe, A., et al. (2021). β-Hydroxybutyrate is protective in acute heart failure through mitochondrial redox balance maintenance. European Journal of Heart Failure, 23(5), 797-809.
10. Courchesne-Loyer, A., et al. (2017). Acute β-hydroxybutyrate supplementation improves exercise performance in trained athletes. Cell Metabolism, 25(3), 725-730.
11. Newport, M. T., et al. (2015). Ketones as alternative fuel for the brain: review of human data. Epilepsy & Behavior, 49, 109-112.
12. Cunnane, S. C., et al. (2016). Can ketones help rescue brain fuel supply in later life? Trends in Neurosciences, 39(8), 629-646.
13. Henderson, S. T., et al. (2009). Study of the ketogenic agent AC-1202 in mild to moderate Alzheimer’s disease: a randomized, double-blind, placebo-controlled, multicenter trial. Nutrition & Metabolism, 6(1), 31.
14. Gasior, M., et al. (2006). Neuroprotective and disease-modifying effects of the ketogenic diet. Behavioural Pharmacology, 17(5-6), 431-439.
15. Masino, S. A., et al. (2011). Ketogenic diets and epilepsy: the emerging therapeutic role of the ketogenic diet in central nervous system disorders. Epilepsy Currents, 11(1), 1-3.
16. Hartman, A. L., et al. (2007). The ketogenic diet: an effective treatment for intractable childhood epilepsy. Epilepsia, 48(1), 31-39.
17. Bailes, J. E., et al. (2000). Ketogenic diet and traumatic brain injury. The Lancet, 356(9242), 1642-1643.
18. Hashim, S. A., et al. (1969). Ketogenic diet for obesity. The American Journal of Clinical Nutrition, 22(1), 45-53.
19. Bueno, N. B., et al. (2013). Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials. British Journal of Nutrition, 110(7), 1178-1187.
20. Paoli, A. (2014). Ketogenic diet for obesity: friend or foe?. International Journal of Environmental Research and Public Health, 11(2), 2092-2107.
21. Kohli, R., et al. (2024). Effects of ketone bodies on cognitive outcomes in adults with mild cognitive impairment or alzheimer’s disease: A meta-analysis of randomised controlled trials. Alzheimer’s & Dementia: Translational Research & Clinical Interventions, 10(2), e12506.